ERVW-1 and infection: After infection with HIV-1, the vast majority of patients develop antibodies that bind to HIV-1 Env, while only a small subset develop antibodies that are neutralizing, as the process of inducing such broadly neutralizing antibodies (bNAbs) faces significant challenges.